Clinical Trial: Phase 2 Trials of NA-931 to Study Subjects Who Are Obese With at Least One Weight-related Comorbid Condition
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Weight Loss
Study Type: INTERVENTIONAL
Official Title: A Phase 2 Randomized, Double-Blind, Placebo-Controlled, 13-week Study of NA-931 for Weight Management in Subjects Who Are Obese or Overweight With at Least One Weight-related Comorbid Condition
Brief Summary:
This is a Phase 2 randomized, double-blind, placebo-controlled, parallel arm study of NA-931 in adults who are obese (BMI ?30 kg/m2) or who are overweight (BMI ?27 kg/m2) with at least one weight-related co-morbid condition.
Read more